You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 714 ATOR-1017, a 4–1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
714 ATOR-1017, a 4–1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022374027
Dec 20227007
Jan 202362026
Feb 20235405
Mar 202360025
Apr 20239808
May 20238607
Jun 20235005
Jul 20232807
Aug 20233404
Sep 20234806
Oct 20239608
Nov 20234203
Dec 20234607
Jan 20241801
Feb 20241804
Mar 20243202
Apr 20242602
May 20242402
Jun 20242001
Jul 20241804
Aug 20241804
Total13220165